About Lirum Therapeutics
Lirum Therapeutics is a private company based in New York, New York, incorporated in 2021 in Delaware. It has reported $6,300,000 raised in one offering on Form D since February 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 8, 2023 | Feb 23, 2023 | $6,300,000of $10.0M target | 53 | $118K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Lirum Therapeutics's Form D filed Feb 23, 2023.
DH
Daniel Hume
Director
KH
Kenneth Hoberman
Executive officer and director
MS
Mark Sard
Director
IB
Ivan Bergstein
Director